Orthobiologics Market Analysis North America, Europe, EMEA, APAC : US, Canada, China, Germany, UK - Forecast 2023-2027

Published: Dec 2022 Pages: 169 SKU: IRTNTR70811

Orthobiologics Market Forecast 2023-2027:

The Orthobiologics Market size is estimated to grow by USD 2.64 billion between 2022 and 2027, accelerating at a CAGR of 7.88% during the forecast period. The market's growth is influenced by various factors, including the increasing prevalence of orthopedic disorders, especially among the aging population. Additionally, there is a growing focus on reducing orthopedic surgeries, and the market is witnessing a rise in approvals and clearances for such products. However, the market faces challenges, such as high costs and inadequate reimbursements for such products and procedures, concerns associated with their use, and stringent regulations. Despite these challenges, the market is experiencing positive trends, including the development of new products, emerging technological innovations, and the rising popularity of orthobiologics. 

Market Growth and Forecasting

To learn more about this report, Request Free Sample

Market Segmentation

This market research report extensively covers market segmentation by application (spinal fusion, reconstructive surgery, trauma repair, and others), product (bone graft substitutes, viscosupplementation, and stem cells), and geography (North America, Europe, Asia, and the Rest of World (ROW)).

By Application

The market share by the spinal fusion segment will be significant during the forecast period. Spinal fusion or spinal arthrodesis is a technique that permanently joins two or more vertebrae in the spine to increase stability, repair a deformity, or relieve discomfort. Patients with spinal disorders such as spinal abnormalities, spinal weakness or instability, and herniated discs can benefit from this therapy. As a result, orthobiologics improve the efficacy of spinal fusion surgeries by healing the targeted site. Such orthobiologic advantages in spinal fusion procedures will drive orthobiologic demand over the projection period.

Get a glance at the market contribution of various segments Request a PDF Sample

The spinal fusion segments show a gradual increase in the market share of USD 2.31 billion in 2017. The higher prevalence of spine-related issues is anticipated to drive the spine fusion application segment in the market. Scoliosis affects 2-3 percent of the population, or around six to nine million persons in the United States, according to data from the National Scoliosis Foundation. People in their thirties and fifties are more prone to it. Above mentioned spinal disorders are generally treated with spinal fusion procedures. Thus, a higher prevalence of such diseases is expected to boost the growth of the spinal fusion segment in the market.

By Region

For more insights on the market share of various regions Request PDF Sample now!

North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. North America dominated the market and is expected to maintain its position during the projection period due to the presence of a well-established healthcare system that provides high-quality orthobiologics. Obesity and an increase in the prevalence of arthritis have increased the demand for minimally invasive procedures such as bone grafting. The increase in sports injuries across North America is also a major factor driving the market. 

Market Dynamics and Customer Landscape

The market thrives at the intersection of regenerative medicine and orthopedic procedures, offering solutions for various conditions like bone diseases, tumors, and infections. These treatments address traumas, fractures, and lesions, promoting healing and regeneration. Utilizing biocomposites and bone morphogenetic proteins, companies like Prosidyan and Fibergaft develop innovative bone graft substitutes. These products find application in hospitals, ASCs, and specialty clinics, catering to diverse needs like maxillofacial fractures and injuries from automobile accidents and sports. They aid in pain management and rehabilitation, catering to patients with chronic illnesses and aiding in recovery from joint and muscle injuries. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

The increasing prevalence of orthopedic disorders coupled with an aging population is a key factor in the growth of the market. There has been an increase in the number of orthopedic disorders across the world over the last decade. Limited physical activity and eating habits can negatively influence the body's homeostasis. This issue worsens with age, putting most persons aged 60 and up vulnerable to orthopedic disorders such as arthritis. Further, orthobiologics, including fibergaft bone graft substitutes, play a vital role in treating bone tumors, infections, bone lesions, and bone fractures, offering innovative solutions to enhance bone healing and regeneration in orthopedic procedures.

Further, orthobiologic products utilized by sports science physicians offer innovative solutions for treating joint injuries, providing alternatives to traditional pain medication and facilitating natural healing processes in orthopedic care. According to the CDC, approximately 65.6% of persons aged 65 and up will visit dental surgeons in 2023. Due to the rise in the prevalence of orthopedic problems, orthobiologics are required for the fixation or binding of joint disorders. Thus, the increasing number of orthopedic disorders will increase the demand and thus drive market growth.

Significant Market Trends

The increase in the development of new products is a key trend in the market's growth. These product launches will encourage other market players to invest in developing advanced products to maintain their position in the market. Therefore, the introduction of new products will support the revenue inflow in the market during the forecast period. Many companies offering orthobiologics, such as SeaSpine Holdings Corp and Bioventus LLC, are focusing on the development of new products to cater to customers with specific requirements.

Furthermore, the rise in popularity of orthobiologics will drive market growth. Orthobiologics therapy focuses on using the healing and rejuvenating properties of the body's own cells for the repair of damaged tissues. Some of the innovative orthobiologics options which are helpful in the treatment of osteoarthritis include platelet-rich plasma (PRP), adipose tissue-derived mesenchymal stem cells (ADMSC), bone marrow concentrate (BMC), autologous chondrocyte implantation (ACI), and autologous conditioned serum. The availability of such products has resulted in preventing operative procedures such as knee arthroplasty for the treatment of osteoarthritis. This, in turn, is anticipated to boost the growth of the market over the forecast period.

Major Market Challenge

The high costs and inadequate reimbursements for products and procedures are major challenges to the market growth. The growing geriatric population, combined with a growth in the number of orthopedic illnesses, has boosted the demand. Advanced ortho biologics products are widely available on the market, particularly in developed countries like the United States. However, the expensive cost of these products prevents them from being widely adopted in emerging and underdeveloped economies. 

For instance, reimbursement is complex in the US due to stringent FDA regulations and the multi-payor system. The high costs of such products, such as new bone grafts, also make reimbursement challenging, leading to low adoption rates in economically depressed countries. Therefore, for manufacturers to be successful, the development of a comprehensive plan for reimbursement before obtaining FDA approval becomes essential. The impact of these factors, however, is expected to reduce in the near future, as many manufacturers are planning to develop affordable products. 

Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Market Customer Landscape

Who are the Major Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Advanced Medical Solutions Group Plc: The company offers orthobiologics solutions that include synthetic bone substitutes, collagen membranes, and bioabsorbable screws.

The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

  • Advanced Medical Solutions Group Plc
  • Anika Therapeutics Inc.
  • Bioventus LLC
  • Globus Medical Inc.
  • Integra Lifesciences Holdings Corp.
  • Johnson and Johnson
  • Kuros Biosciences AG
  • Medtronic Plc
  • MTF Biologics
  • Nuvasive Inc
  • Orthofix Medical Inc.
  • OrthoPediatrics Corp.
  • ROYAL BIOLOGICS
  • RTI Surgical Inc.
  • SeaSpine Holdings Corp.
  • Smith and Nephew plc
  • Stryker Corp.
  • Xtant Medical Inc.
  • Zimmer Biomet Holdings Inc.
  • Arthrex Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Segment Overview

The market analysis report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Application Outlook
    • Spinal fusion
    • Reconstructive surgery
    • Trauma repair
    • Others
  • ProductOutlook 
    • Bone graft substitutes
    • Viscosupplementation
    • Stem cells
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World
      • Brazil
      • Argentina
      • Australia

Market Analyst Overview

The market is thriving due to the rising prevalence of bone infections and musculoskeletal diseases. With innovations like stem cell-based allografts and viscosupplements, patients are benefiting from improved treatment options. Procedures such as total knee replacement and soft tissue repair are facilitated by advancements in bone growth factors and cellular allografts. Companies like Depuy Synthes are at the forefront of providing solutions for shoulder, knee, and elbow injuries. However, challenges like the coronavirus pandemic and backlog of surgeries due to elective surgery delays impact the market dynamics, affecting orthopedic patients and senior persons alike.

Additionally, the market plays a pivotal role in addressing a wide range of orthopedic conditions. From bone injuries to shoulder injuries and knee osteoarthritis, orthobiologics offer innovative solutions for patients. Utilizing advanced treatments such as Demineralized Bone Matrix (DBM) and Bmp-based treatments, orthopedic surgeons can perform reconstructive and fracture surgery with improved outcomes. Additionally, orthobiologics contribute to the treatment of hip and backbone fractures, catering to patients in Hospitals & Ambulatory Surgical Centers (ASCs). Despite challenges like the coronavirus pandemic and PPE shortages, orthobiologics continue to enhance patient care and non-surgical treatment options.

Market Scope

Report Coverage

Details

Page number

169

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 7.88%

Market growth 2023-2027

USD 2.64 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

6.95

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 41%

Key countries

US, Canada, UK, Germany, and China

Competitive landscape

 Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks

Key companies profiled

Advanced Medical Solutions Group Plc, Anika Therapeutics Inc., Bioventus LLC, Globus Medical Inc., Integra Lifesciences Holdings Corp., Johnson and Johnson, Kuros Biosciences AG, Medtronic Plc, MTF Biologics, Nuvasive Inc, Orthofix Medical Inc., OrthoPediatrics Corp., ROYAL BIOLOGICS, RTI Surgical Inc., SeaSpine Holdings Corp., Smith and Nephew plc, Stryker Corp., Xtant Medical Inc., Zimmer Biomet Holdings Inc., and Arthrex Inc.

Market dynamics

 Parent Market Analysis; Market growth inducers and obstacles; Fast-growing, market report, and slow-growing segment analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request free sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
  • Precise estimation of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global orthobiologics market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global orthobiologics market 2017 - 2021 ($ million)
    • 4.2 By Application Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – By Application Segment 2017 - 2021 ($ million)
    • 4.3 By Product Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – By Product Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
    • 6.2 Comparison by Application
      • Exhibit 32: Chart on Comparison by Application
      • Exhibit 33: Data Table on Comparison by Application
    • 6.3 Spinal fusion - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Spinal fusion - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Spinal fusion - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Spinal fusion - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Spinal fusion - Year-over-year growth 2022-2027 (%)
    • 6.4 Reconstructive surgery - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Reconstructive surgery - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Reconstructive surgery - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Reconstructive surgery - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Reconstructive surgery - Year-over-year growth 2022-2027 (%)
    • 6.5 Trauma repair - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Trauma repair - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Trauma repair - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Trauma repair - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Trauma repair - Year-over-year growth 2022-2027 (%)
    • 6.6 Others - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.7 Market opportunity by Application
      • Exhibit 50: Market opportunity by Application ($ million)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 51: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 52: Data Table on Product - Market share 2022-2027 (%)
    • 7.2 Comparison by Product
      • Exhibit 53: Chart on Comparison by Product
      • Exhibit 54: Data Table on Comparison by Product
    • 7.3 Bone graft substitutes - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Bone graft substitutes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 56: Data Table on Bone graft substitutes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Chart on Bone graft substitutes - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Bone graft substitutes - Year-over-year growth 2022-2027 (%)
    • 7.4 Viscosupplementation - Market size and forecast 2022-2027
      • Exhibit 59: Chart on Viscosupplementation - Market size and forecast 2022-2027 ($ million)
      • Exhibit 60: Data Table on Viscosupplementation - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Chart on Viscosupplementation - Year-over-year growth 2022-2027 (%)
      • Exhibit 62: Data Table on Viscosupplementation - Year-over-year growth 2022-2027 (%)
    • 7.5 Stem cells - Market size and forecast 2022-2027
      • Exhibit 63: Chart on Stem cells - Market size and forecast 2022-2027 ($ million)
      • Exhibit 64: Data Table on Stem cells - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Chart on Stem cells - Year-over-year growth 2022-2027 (%)
      • Exhibit 66: Data Table on Stem cells - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Product
      • Exhibit 67: Market opportunity by Product ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 69: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 70: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 71: Chart on Geographic comparison
      • Exhibit 72: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 UK - Market size and forecast 2022-2027
      • Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.9 Germany - Market size and forecast 2022-2027
      • Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.10 China - Market size and forecast 2022-2027
      • Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.11 Canada - Market size and forecast 2022-2027
      • Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 109: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 110: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 112: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 113: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 114: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 115: Matrix on vendor position and classification
            • 12.3 Advanced Medical Solutions Group Plc
              • Exhibit 116: Advanced Medical Solutions Group Plc - Overview
              • Exhibit 117: Advanced Medical Solutions Group Plc - Business segments
              • Exhibit 118: Advanced Medical Solutions Group Plc - Key offerings
              • Exhibit 119: Advanced Medical Solutions Group Plc - Segment focus
            • 12.4 Anika Therapeutics Inc.
              • Exhibit 120: Anika Therapeutics Inc. - Overview
              • Exhibit 121: Anika Therapeutics Inc. - Product / Service
              • Exhibit 122: Anika Therapeutics Inc. - Key offerings
            • 12.5 Arthrex Inc.
              • Exhibit 123: Arthrex Inc. - Overview
              • Exhibit 124: Arthrex Inc. - Product / Service
              • Exhibit 125: Arthrex Inc. - Key offerings
            • 12.6 Bioventus LLC
              • Exhibit 126: Bioventus LLC - Overview
              • Exhibit 127: Bioventus LLC - Business segments
              • Exhibit 128: Bioventus LLC - Key news
              • Exhibit 129: Bioventus LLC - Key offerings
              • Exhibit 130: Bioventus LLC - Segment focus
            • 12.7 Globus Medical Inc.
              • Exhibit 131: Globus Medical Inc. - Overview
              • Exhibit 132: Globus Medical Inc. - Product / Service
              • Exhibit 133: Globus Medical Inc. - Key offerings
            • 12.8 Johnson and Johnson
              • Exhibit 134: Johnson and Johnson - Overview
              • Exhibit 135: Johnson and Johnson - Business segments
              • Exhibit 136: Johnson and Johnson - Key news
              • Exhibit 137: Johnson and Johnson - Key offerings
              • Exhibit 138: Johnson and Johnson - Segment focus
            • 12.9 Medtronic Plc
              • Exhibit 139: Medtronic Plc - Overview
              • Exhibit 140: Medtronic Plc - Business segments
              • Exhibit 141: Medtronic Plc - Key news
              • Exhibit 142: Medtronic Plc - Key offerings
              • Exhibit 143: Medtronic Plc - Segment focus
            • 12.10 Nuvasive Inc
              • Exhibit 144: Nuvasive Inc - Overview
              • Exhibit 145: Nuvasive Inc - Business segments
              • Exhibit 146: Nuvasive Inc - Key news
              • Exhibit 147: Nuvasive Inc - Key offerings
              • Exhibit 148: Nuvasive Inc - Segment focus
            • 12.11 Orthofix Medical Inc.
              • Exhibit 149: Orthofix Medical Inc. - Overview
              • Exhibit 150: Orthofix Medical Inc. - Business segments
              • Exhibit 151: Orthofix Medical Inc. - Key news
              • Exhibit 152: Orthofix Medical Inc. - Key offerings
              • Exhibit 153: Orthofix Medical Inc. - Segment focus
            • 12.12 OrthoPediatrics Corp.
              • Exhibit 154: OrthoPediatrics Corp. - Overview
              • Exhibit 155: OrthoPediatrics Corp. - Business segments
              • Exhibit 156: OrthoPediatrics Corp. - Key news
              • Exhibit 157: OrthoPediatrics Corp. - Key offerings
              • Exhibit 158: OrthoPediatrics Corp. - Segment focus
            • 12.13 ROYAL BIOLOGICS
              • Exhibit 159: ROYAL BIOLOGICS - Overview
              • Exhibit 160: ROYAL BIOLOGICS - Product / Service
              • Exhibit 161: ROYAL BIOLOGICS - Key offerings
            • 12.14 RTI Surgical Inc.
              • Exhibit 162: RTI Surgical Inc. - Overview
              • Exhibit 163: RTI Surgical Inc. - Product / Service
              • Exhibit 164: RTI Surgical Inc. - Key offerings
            • 12.15 SeaSpine Holdings Corp.
              • Exhibit 165: SeaSpine Holdings Corp. - Overview
              • Exhibit 166: SeaSpine Holdings Corp. - Business segments
              • Exhibit 167: SeaSpine Holdings Corp. - Key offerings
              • Exhibit 168: SeaSpine Holdings Corp. - Segment focus
            • 12.16 Smith and Nephew plc
              • Exhibit 169: Smith and Nephew plc - Overview
              • Exhibit 170: Smith and Nephew plc - Business segments
              • Exhibit 171: Smith and Nephew plc - Key news
              • Exhibit 172: Smith and Nephew plc - Key offerings
              • Exhibit 173: Smith and Nephew plc - Segment focus
            • 12.17 Stryker Corp.
              • Exhibit 174: Stryker Corp. - Overview
              • Exhibit 175: Stryker Corp. - Business segments
              • Exhibit 176: Stryker Corp. - Key news
              • Exhibit 177: Stryker Corp. - Key offerings
              • Exhibit 178: Stryker Corp. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 179: Inclusions checklist
                • Exhibit 180: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 181: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 182: Research methodology
                • Exhibit 183: Validation techniques employed for market sizing
                • Exhibit 184: Information sources
              • 13.5 List of abbreviations
                • Exhibit 185: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              orthobiologics market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis